Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Ozempic, Wegovy and Mounjaro can reduce risk of heart disease, dementia, and much more, says groundbreaking US study ...

Weight-loss jabs could reduce your risk of drug abuse, seizures and pneumonia, as well as heart attacks and strokes, ...

GLP-1 medications like Ozempic, Wegovy, and Mounjaro are linked to reduced risks of dementia, heart failure, and severe ...

The family of a Houghton Regis boy who is still recovering after a heart attack nearly a year ago are pleading for donations as they rebuild their lives.

GLP-1 agents "have an intricate web of various effects," Al-Aly said in a press briefing. For example, the analysis showed ...

Glucagon-like peptide-1 receptor agonist use corresponded with risk reductions for dozens of diseases and adverse health ...

Today in History for Jan. 19: ...

UNC Health Southeastern experienced numerous successes and enhancements to services, in addition to being recognized ...